2021
DOI: 10.1021/acs.jafc.0c05395
|View full text |Cite
|
Sign up to set email alerts
|

Microfluidic Assembly: An Innovative Tool for the Encapsulation, Protection, and Controlled Release of Nutraceuticals

Abstract: Nutraceuticals have been gradually accepted as food ingredients that can offer health benefits and provide protection against several diseases. It is widely accepted due to potential nutritional benefits, safety, and therapeutic effects. Most nutraceuticals are vulnerable to the changes in the external environment, which leads to poor physical and chemical stability and absorption. Several researchers have designed various encapsulation technologies to promote the use of nutraceuticals. Microfluidic technology… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 125 publications
(232 reference statements)
1
7
0
Order By: Relevance
“…S1 †). All signals for 1 H NMR were in good agreement with the block copolypeptide structures (Fig. 2 and Fig.…”
Section: Surfactant Synthesissupporting
confidence: 79%
See 2 more Smart Citations
“…S1 †). All signals for 1 H NMR were in good agreement with the block copolypeptide structures (Fig. 2 and Fig.…”
Section: Surfactant Synthesissupporting
confidence: 79%
“…No precipitation was observed during any of these steps or after dialysis signifying high stability of the core forming homopolypeptide within the core of the nanoparticles. Spectroscopically the presence of the core homopolypeptide and the surfactant in the nanoparticles after dialysis was confirmed by comparative 1 H NMR spectra which were recorded in d-TFA as a common solvent for surfactant and core polypeptide. Fig.…”
Section: Mini-emulsion Polymerizationmentioning
confidence: 88%
See 1 more Smart Citation
“…In the preparation of liposomes, microfluidic technology can replace the lipid hydration and extrusion steps with a single-step production process in which particle size is process-controlled. [59][60][61] Further, the encapsulation and loading efficiency of DOX in liposomes can be adjusted by changing the concentration of drug and encapsulated nanoparticles. The encapsulation efficiency decreased with the increasing concentration of drug and encapsulated nanoparticles, while the loading efficiency was positively correlated with the drug concentration.…”
Section: Dovepressmentioning
confidence: 99%
“…With high specific surface area and good fluidity, polymer porous microspheres have played an important role in a wide range of biomedical applications, such as controllable drug delivery, adsorbent, cell delivery, and enzyme immobilization [1][2][3][4][5][6]. The employment of microfluidics has facilitated the development of various solid microspheres and particles due to the enhanced precision and controllability [7][8][9][10][11]. However, precise fabrication of porous microspheres is still a challenge since the rapid phase separation damages the emulsion template and further impairs the uniformity of the microspheres in particle size and pore structure [12], which limits the yield and application of porous microspheres.…”
Section: Introductionmentioning
confidence: 99%